Home › Research › Tau biomarkers
Cardiovascular Health at Midlife and Alzheimer Disease Biomarkers
Dintica CS, Jiang X, Shaw LM, Bryan RN, Yaffe K.. medRxiv, 2026-04-17
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
ABSTRACT Background Cardiovascular health factors are associated with cognitive decline and risk of dementia, including Alzheimer disease (AD); however, this has been mostly studied in late life. We investigated whether vascular and lifestyle factors are associated with AD plasma and imaging biomarkers in midlife. Methods We investigated 1,406 participants from the Coronary Artery Risk Development in Young Adults (CARDIA) study with information on vascular and lifestyle factors framed from the American Heart Association (AHA) “life’s essential 8” (LE8) guidelines for cardiovascular health at early midlife (mean age 45.0 ± SD 3.6) and AD biomarkers in late midlife (mean age 60 ± SD 3.5).
What this study adds
Evidence grade: Low
The record lists 1,406 participants. It examines associations with biomarkers and does not show that any intervention treats, cures, or prevents Alzheimer's disease. Reported effect size: 67.9%; 12.6%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Dintica, C. S., Jiang, X., Shaw, L. M., Bryan, R. N., & Yaffe, K. (2026). Cardiovascular Health at Midlife and Alzheimer Disease Biomarkers. medRxiv. https://doi.org/10.64898/2026.04.15.26350968
Vancouver
Dintica CS, Jiang X, Shaw LM, Bryan RN, Yaffe K. Cardiovascular Health at Midlife and Alzheimer Disease Biomarkers. medRxiv. 2026. doi:10.64898/2026.04.15.26350968.
BibTeX
@article{dintica2026-37136884,
author = {Dintica, C. S. and Jiang, X. and Shaw, L. M. and Bryan, R. N. and Yaffe, K.},
title = {{Cardiovascular Health at Midlife and Alzheimer Disease Biomarkers}},
journal = {medRxiv},
year = {2026},
doi = {10.64898/2026.04.15.26350968},
url = {https://doi.org/10.64898/2026.04.15.26350968}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- We investigated whether vascular and lifestyle factors are associated with AD plasma and imaging biomarkers in midlife.
- Methods We investigated 1,406 participants from the Coronary Artery Risk Development in Young Adults (CARDIA) study with information on vascular and lifestyle factors framed from the American Heart Association (AHA) “life’s essential 8” (LE8) guidelines for cardiovascular health at early midlife (mean age 45.0 ± SD 3.6) and AD biomarkers in late midlife (mean age 60 ± SD 3.5).
- LE8 was calculated and categorized into poor (0-49), intermediate (50-79), and ideal (80-100) cardiovascular health, based on 8 components including smoking, diet, body mass index (BMI), sleep, fasting glucose, blood pressure, cholesterol, and physical activity.
- We assessed the AD plasma biomarkers phosphorylated tau 217 (ptau-217) and amyloid beta 42/40 ratio (Aβ42/40) and the Spatial Pattern of Abnormality for Recognition of Early AD (SPARE-AD), an algorithm that characterizes AD-like brain atrophy on brain MRI.
Why it matters
Among 1,406 participants in the CARDIA study, this work investigated whether cardiovascular health factors at early midlife, framed by the American Heart Association's life's essential 8 guidelines, were associated with Alzheimer's disease plasma and imaging biomarkers at late midlife. It examines associations with biomarkers and does not show that any intervention treats, cures, or prevents Alzheimer's disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants1,406
- Effect size67.9%; 12.6%
- Evidence strengthLow
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 32 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on impact for its field and year, so that was left out: it earned 30 of the 94 points we could judge it on, which is 32 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (medRxiv) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 3 / 4 | 1,406 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Kristine S. Yaffe: h-index 155 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of California, San Francisco: institution h-index 1,915 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 30 / 94 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 30 of the 94 points we could judge it on is 32 out of 100. |
| Total | 32 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.